1. Home
  2. EVC vs IAM Comparison

EVC vs IAM Comparison

Compare EVC & IAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

N/A

Current Price

$6.50

Market Cap

683.9M

Sector

Industrials

ML Signal

N/A

IAM

Iambic Therapeutics Inc. Common Stock

N/A

Current Price

$13.10

Market Cap

683.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVC
IAM
Founded
1996
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
683.9M
683.0M
IPO Year
2000
2026

Fundamental Metrics

Financial Performance
Metric
EVC
IAM
Price
$6.50
$13.10
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 1.1M
708.9K
Earning Date
11-05-2026
11-19-2026
Dividend Yield
★ 3.28%
N/A
EPS Growth
★ 47.59
N/A
EPS
★ 0.32
N/A
Revenue
★ $536,034,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.02
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.98
$12.39
52 Week High
$13.74
$24.49

Technical Indicators

Market Signals
Indicator
EVC
IAM
Relative Strength Index (RSI) 43.29 7.35
Support Level $6.43 N/A
Resistance Level $10.09 $16.50
Average True Range (ATR) 0.31 2.28
MACD 0.07 -0.53
Stochastic Oscillator 63.64 7.98

Price Performance

Historical Comparison
EVC
IAM

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About IAM Iambic Therapeutics Inc. Common Stock

Iambic Therapeutics Inc is a technology and clinical-stage life sciences company developing novel medicines using its proprietary molecular superintelligence platform.

Share on Social Networks: